ALZ-101 ALZ-101, Alzinova’s therapeutic vaccine candidate for Alzheimer’s disease. GOTHENBURG, Sweden, Sept. 21, 2026 (GLOBE NEWSWIRE) — As World Alzheimer’s Day highlights the continued unmet need in Alzheimer’s disease, Swedish clinical-stage biopharmaceutical company Alzinova AB (Nasdaq First North: ALZ) is advancing on two fronts: initiating…
Canada News
Pearce Carpenter says fixing the holes in the black balloon bottoms they bought from an Edmonton thrift store is their way of tackling fast…
Lifestyle
A centre dedicated to supporting people with dyslexia is getting a permanent home in Vancouver, with a focus on helping…
Tech & Innovation
Today, I’m talking with Mark Gurman, who is the world’s best-sourced Apple reporter — both as Bloomberg’s chief Apple correspondent and the host of the upcoming…